JPRN-UMIN000016184
已完成
2 期
Clinical trial on Efficacy and Safey of dual bronchodilator (glycopyronium and indacaterol) in perioperative management of chest surgery - Phase II study of glycopyronium and indacaterol in chest surgery
niversity of Miyazaki Hospital Department of Surgery II0 个研究点目标入组 160 人2015年1月12日
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- ung cancer, thoracic malignant diseases (metastatic tumors due to breast cancer, colon cancer, and other malignancies), and benign pulmonary tumors
- 发起方
- niversity of Miyazaki Hospital Department of Surgery II
- 入组人数
- 160
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\)closed angle glaucoma 2\)prostatomegaly and dysuria 3\)past medical history of hypersensitivity, allergy 4\)bronchodilator treatment except for LAMA/LABA and LABA 5\)under treatment of Bronchial asthma 6\)severe hypokalemia 7\)atrial fibrillation 8\)Others. Patients judged for inappropriation by attending physician or lead principal investigator
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
Evaluation of the efficacy and safety of dual biologic and/or small molecule therapy in patients with induction-resistant ulcerative colitis (RESPECT).lcerative colitisMedDRA version: 20.1Level: LLTClassification code: 10045365Term: Ulcerative colitis Class: 10017947Therapeutic area: Diseases [C] - Immune System Diseases [C20]Therapeutic area: Diseases [C] - Digestive System Diseases [C06]CTIS2023-506628-98-00Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy180
进行中（未招募）
1 期
Evaluation of the efficacy and safety of dual biological therapy in patients with refractory Crohn's disease resistant to induction (FLAMING).Crohn's diseaseMedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Therapeutic area: Diseases [C] - Immune System Diseases [C20]CTIS2023-506626-37-00Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy192
尚未招募
不适用
Clinical study to evaluate the role of basti karma (enema therapy) and virechan karma (purgation therapy) in hyperuricemia.Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous diseaseCTRI/2024/07/069925Ayurvedic and Unani Tibbia College and Hospital
进行中（未招募）
1 期
Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients.EUCTR2018-003300-39-ESFundación para la Investigación Biomédica de Córdoba150
进行中（未招募）
不适用
Comparison of the efficacy and safety of two different dose adjustment regimens for insulin degludec/insulin aspart in subjects with type 2 diabetes mellitus previously treated with insulin glargineDiabetes Mellitus, Type 2MedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2012-000373-23-DEovo Nordisk A/S270